Mineralys Therapeutics, Inc. (MLYS)
Market Open
1 Sep, 19:43
NASDAQ (NGS) NASDAQ (NGS) Primary $
25. 30
-0.37
-1.4546%
$
2.26B Market Cap
- P/E Ratio
- Div Yield
495,833 Volume
-2.58 Eps
$ 25.67
Previous Close 
Want to track MLYS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
MLYS Earnings Reports FAQ
What is the earnings per share (EPS) for MLYS?
The current EPS is -2.58.
What is the company's earnings growth rate?
Mineralys Therapeutics, Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Mineralys Therapeutics, Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Mineralys Therapeutics, Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for MLYS at this time, as Mineralys Therapeutics, Inc has no recent EPS data to calculate it.
